Prothena Corp Public PRTA
NASDAQ PRTA
$9.82 +0.22 (+2.29%)
As of: Sep 4, 2026 · 3:59 PM EDT

Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024)

Prothena Corp Public (PRTA) posted quarterly Short-term Investments of $1.4 million for Q1 2024, little changed quarter-over-quarter from $1.4 million in Q4 2023.

Analysis

Prothena Corp Public (PRTA) Short-term Investments (2019 - 2024) Analysis & Trends

Prothena Corp Public's Short-term Investments history runs 5 years deep, the most recent figure standing at $1.4 million for Q1 2024.

  • In Q1 2024, Short-term Investments changed N/A year-over-year to $1.4 million; the TTM figure through Mar 2024 stood at $1.4 million (changed N/A YoY), while the FY2023 annual figure was $1.4 million, changed N/A from the prior year.
  • Short-term Investments for Q1 2024 stood at $1.4 million, roughly flat from $1.4 million in the prior quarter.
  • The five-year high for Short-term Investments was $1.4 million in Q3 2020, with the low at $1.4 million in Q3 2020.
  • The 4-year median for Short-term Investments is $1.4 million (2020), against an average of $1.4 million.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Prothena Corp Public 513.11 Mn 224.91 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.35 Mn
Dec 31, 2023 1.35 Mn
Sep 30, 2023 1.35 Mn
Jun 30, 2023 1.35 Mn
Jun 30, 2021 1.35 Mn
Mar 31, 2021 1.35 Mn
Dec 31, 2020 1.35 Mn
Sep 30, 2020 1.35 Mn
Jun 30, 2019 1.35 Mn
Mar 31, 2019 1.35 Mn